Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
Date:5/10/2013

THE WOODLANDS, Texas, May 10, 2013 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months  ended March 31, 2013.

"In the first quarter of 2013, we continued to progress our clinical pipeline on multiple fronts. Most notably, we initiated a Phase 2 trial of LX4211, our dual inhibitor of SGLT1 and SGLT2, in patients with type 1 diabetes", said Dr. Arthur T. Sands, president and chief executive officer of Lexicon. "We continue to see opportunities for LX4211 as a potential therapy for a broad spectrum of diabetic conditions including type 1 and type 2 diabetes and diabetes with renal impairment."

Progress in Clinical Pipeline

  • LX4211:  Lexicon is proceeding with preparations for the initiation of Phase 3 clinical trials of LX4211 in type 2 diabetes.  Lexicon also initiated a Phase 2 clinical trial of LX4211 in type 1 diabetes and continues to enroll patients in a clinical trial evaluating LX4211 in type 2 diabetes patients with renal impairment.  LX4211 is a dual inhibitor of sodium-glucose transporter 2 (SGLT2), which is responsible for most of the glucose reabsorption performed by the kidney, and sodium-glucose transporter 1 (SGLT1), which is responsible for glucose and galactose absorption in the gastrointestinal tract and, to a lesser degree than SGLT2, glucose reabsorption in the kidney.
  • Telotristat etiprate (LX1032):  Lexicon continues to enroll pat
    '/>"/>

  • SOURCE Lexicon Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial
    2. Lexicon to Report First Quarter Financial Results on May 10, 2013
    3. Lexicon To Present At The Needham Healthcare Conference
    4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
    5. Lexicon To Present At The BIO CEO & Investor Conference
    6. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
    7. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
    8. Lexicon to Provide Third Quarter 2012 Financial Results
    9. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
    10. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
    11. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/18/2014)... WARSAW, Ind. , Nov. 18, 2014  Zimmer ... that it has agreed with the European Commission (the ... of Zimmer,s proposed acquisition of Biomet by a limited ... with certain additional information. Deadline extensions ... been working closely with the regulatory authorities to facilitate ...
    (Date:11/18/2014)... 2014  Cardica, Inc. (Nasdaq: CRDC ... approved management,s recommendation to shift Cardica,s primary focus ... XCHANGE® 30 surgical stapler to improving its performance ... result, Cardica has temporarily suspended the controlled commercial ... of the MicroCutter XCHANGE 30 surgical stapler from ...
    (Date:11/18/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) ... Monday, December 8, 2014 at 9:00 a.m. Eastern Time to ... th American Society of Hematology Annual Meeting and Exposition.  ... by dialing 877-443-5662 or access the webcast at www.isispharm.com ... time at the same address. ABOUT ISIS ...
    Breaking Medicine Technology:Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Cardica Announces Shift In Focus 2Cardica Announces Shift In Focus 3Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3
    ... May 26, 2011 Kensey Nash Corporation (Nasdaq: ... Global Healthcare Conference at The Grand Hyatt in New York, ... Kaufmann, Kensey Nash,s President and CEO, will deliver the Company,s ... live webcast of the Kensey Nash presentation, go to ...
    ... Pa., May 26, 2011 ViroPharma Incorporated (NASDAQ: ... Swell , a twenty-five minute film that allows families dealing ... share the challenges and triumphs of living with a chronic ... HAE, often times through many generations of the same family. ...
    Cached Medicine Technology:ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema 2ViroPharma Launches 'Swell,' an Original Documentary Chronicling the Lives of People Living with Hereditary Angioedema 3
    (Date:11/18/2014)... 18, 2014 A+ Secure Packaging, ... nutraceutical, dietary supplements and more, announced today that ... Good Manufacturing Practices (GMP) Registration for dietary supplements ... from NSF International verifies the A+ Secure Packaging ... compliance requirements of its clients by demonstrating the ...
    (Date:11/18/2014)... 2014 Recently, Wigsbuy has introduced its ... are offered at greatly discounted prices now, up to 85% ... of human hair products, offering many real and synthetic hair ... global customers, Wigsbuy uses high quality materials to make its ... with the trend. , “We are offering a full ...
    (Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. 17, ... not have significant heart-health benefits for older people, new ... than 14,000 Japanese people aged 60 to 85, found ... attacks and strokes between people who took aspirin and ... prevention with daily low-dose aspirin does not reduce the ...
    (Date:11/18/2014)... By Dennis Thompson HealthDay ... doctor from Sierra Leone who became infected with Ebola in his ... Dr. Martin Salia had arrived Saturday at Nebraska Medical Center ... at a hospital in Sierra Leone,s capital city of Freetown. ... that have been ravaged by the Ebola outbreak that began last ...
    (Date:11/17/2014)... 17, 2014 A Diet Doc ... throughout the country are turning back the clock on ... This is because the company has recently added their ... impressive collection of prescription and non-prescription diet products and ... Diet Doc’s best anti-aging human growth hormone ...
    Breaking Medicine News(10 mins):Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:It Is The Most Wonderful Time To Buy Full Lace Wigs At Wigsbuy.com 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Doctor With Ebola Dies at Nebraska Hospital 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 2Health News:Best Anti-Aging Human Growth Hormone Therapy Safely and Naturally Restores Diet Doc Patients to More Youthful Levels 3
    ... Lower pay, fewer marriages among those who had depression, ... 17 (HealthDay News) -- Children who experience psychological disorders ... headed for a financially depressed adulthood, new research suggests. ... are less likely to get married or maximize their ...
    ... ... Village at ProprietorsGreen, a luxury senior rental community developed by Norwell-based ... has opened in Marshfield, Massachusetts. Despite an economic climate that ... on schedule, and opened with 40 percent of its independent living ...
    ... ... provider of solutions for the workers, compensation and liability markets, announced that it has ... drug requirements pertaining to Medicare Set-Asides (MSA). , ... Tampa, Florida (Vocus) May 17, 2010 -- PMSI ...
    ... diseases in middle age, despite an absence of family history ... blame, according to a new study conducted by researchers at ... the National Institutes of Health. The study also ... help identify those genetic abnormalities and allow detection before the ...
    ... the Queensland Institute of Medical Research (QIMR) and the Royal ... successfully treated it by performing an experimental stem cell transplant. ... out of hospital Katie Pulling had almost given up hope. ... the doctors say, ,We don,t know what is wrong, ,We ...
    ... ... for. Flexible Assembly Systems uncovers the great torque screwdriver mystery with its very own Torque ... (PRWEB) ... know what to look for. A torque screwdriver comes in many different variations, including ...
    Cached Medicine News:Health News:Kids' Psychological Problems Have Long-Term Effects 2Health News:Village at Proprietors Green Opens on South Shore, Introducing Innovative Senior Living to Boston Area 2Health News:PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology 2Health News:PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology 3Health News:Lung disease may be genetic, despite lack of family history 2Health News:Australian researchers identify a new disease 2Health News:Flexible Assembly Systems Announces Torque Screwdriver Application Guide 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: